ArticleClinical cancer research : an official journal of the American Association for Cancer Research2013

γ-H2AX foci formation as a pharmacodynamic marker of DNA damage produced by DNA cross-linking agents: results from 2 phase I clinical trials of SJG-136 (SG2000).

Jenny Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.